3646 results for «504»
3646 results
Management of stent failures
18 May 2023 – From EuroPCR 2023
Join us as we navigate the complexities of stent failures in this session and explore the diverse strategies employed for successful outcomes: learn about the challenges posed by in-stent restenosis following chimney stenting during valve-in-valve TAVI, delve into the dilemma of underexpanded stent restenosis and weigh the...
PCI for complex coronary lesions
18 May 2023 – From EuroPCR 2023
Gain valuable insights into the management of challenging coronary lesions during PCI in this session: witness the effective treatment of in-stent restenosis through the innovative use of intravascular lithotripsy, explore the techniques employed to address non-expandable stents, discover the utility of the Guide Extension catheter system...
EuroPCR 2023 Hotlines/Late-Breaking Trials: from (N)STEMI to Chronic Coronary Syndromes (CCS)
19 May 2023 – From EuroPCR 2023
What are the most significant facts in this respect? Get the essentials by listening to the presenters review some clinical hotlines. To cite a few, Selective Intracoronary hypothermia in anterior wall myocardial infarction; real-time catheter-based microvascular obstruction detection in STEMI : results from the MOCCA I...
How to treat coronary aneurysm
18 May 2023 – From EuroPCR 2023
Treating coronary aneurysms requires careful consideration and depends on several facors such as specifics characteristics of the aneurysms and patient’s conditions. Learn more the way to treat them throught this series of cases: massive thrombosis of an RCA aneurysm ; new insight toward understanding WOVEN like...
EuroPCR 2025 – The FAITAVI trial: angiography versus physiology-guided PCI in patients undergoing TAVI – 12-month follow-up data
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation
31 Aug 2021
Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.
Author
